CJC-1295 + Ipamorelin for Weight Loss: What the Evidence Shows
What human and animal studies show about CJC-1295 + Ipamorelin for weight loss, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human observational
- from an ingredient's studies
- Human studies
- 1
- with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)
- Animal studies
- None found
- with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)
- Studies we summarised
- 2
- with an outcome for weight loss
Evidence for weight loss
Each row is an outcome related to weight loss from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here. No study has tested CJC-1295 + Ipamorelin itself; rows are for each ingredient.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| CJC-1295: Reasons for use reported on forums | Forum users cited weight loss, muscle enhancement, youthful skin, improved sleep and injury healing as reasons for use; these are user-stated motives, not measured results. | Human observational | Substance use & misuse 2016, PMID 26771670 |
| Ipamorelin: Regulatory status and evidence for physique claims | The review notes no regulatory approval for physique- or performance-related indications of these peptides, including ipamorelin. | Review | Frontiers in endocrinology 2026, PMID 42395176 |
CJC-1295 + Ipamorelin and weight loss are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 11 Oct 2026). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What fat-loss searchers are looking for
A netnography of bodybuilding forums found that women who discuss CJC-1295 name weight loss, muscle, skin, sleep and injury healing as their reasons; that describes motivation, not results.[1]
How much weight-loss evidence exists
The CJC-1295 weight-loss ledger query (run 2026-10-02) found 4 human-tagged, 2 human-only and 1 animal record out of 5 in total, and none were randomized trials; no record for the CJC-1295 plus ipamorelin pair is listed.
Calculated from human 4; human only 2; animal 1; rct 0; all 5. Formula: Counts copied from the cjc-1295 ledger row of the weight-loss goal in goals.json; no arithmetic.
A review of GH-axis peptides notes the absence of regulatory approval for physique- or performance-related indications.[2]
What the CJC-1295 trials measured instead of fat
In a CJC-1295 study, trough GH rose 7.5-fold, mean GH 46% and IGF-I 45%.[3]
Other peptides people research for weight loss
All peptides for weight loss, comparedCommon questions
Does CJC-1295 + Ipamorelin help with weight loss?
The strongest study we summarise for weight loss is human observational evidence, for an ingredient rather than the blend, across 2 studies with an outcome for weight loss. That is not proof it works in people.
Is CJC-1295 + Ipamorelin approved for weight loss?
No. CJC-1295 + Ipamorelin is not FDA approved for any use, including weight loss.
What is the best peptide for weight loss?
There is no single answer. Our weight loss overview compares each candidate by evidence grade and legal status rather than by popularity.
Does CJC-1295 with ipamorelin burn fat?
The CJC-1295 trials report GH and IGF-I levels and pharmacokinetics, not fat loss.[4]
Why do people expect fat loss from it?
Forum users described weight loss among their reasons for choosing CJC-1295. The paper reports what users say, not results.[1]
More on CJC-1295 + Ipamorelin
Sources
- 1Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Substance use & misuse · 2016PMID 26771670Accessed 2 Oct 2026
- 2The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026
- 3Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.The Journal of clinical endocrinology and metabolism · 2006PMID 17018654Accessed 2 Oct 2026
- 4Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
Found an error? Report a correction.